← Leaderboards
Masanori Aikawa
Brigham And Women'S Hospital
$9,545,690
Attributed
$10,553,509
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,553,509 · 6
By mechanism
R01$10,513,509 · 5
R13$40,000 · 1
Top collaborators
- Elena Aikawa2 shared
- Sasha A Singh2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Peter Libby$39,585,619
- Bradley Maron$8,442,424
- Andrew H Lichtman$12,069,332
- Guo-Ping Shi$19,551,120
- Frank M Sacks$39,642,820
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationMacrophageIn VitroIn VivoInflammatoryPlayMacrophage ActivationBaseVascular DiseasesNovel TherapeuticsSmall Interfering RnaLinkMouse ModelPathway AnalysisBiologyProteinsLesionCellsGlobal HealthProteomicsFutureAtherosclerosisInterdisciplinary StudyAtherogenesis
Grant awards (19)
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV$739,827
R01 · FY2025 · HL · contact PI
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV$771,902
R01 · FY2024 · HL · contact PI
Pro-inflammatory activation of human macrophages regulated by lncRNAs$723,580
R01 · FY2022 · HL · contact PI
Pro-inflammatory activation of human macrophages regulated by lncRNAs$724,962
R01 · FY2021 · HL · contact PI
Pro-inflammatory activation of human macrophages regulated by lncRNAs$726,322
R01 · FY2020 · HL · contact PI
Pro-inflammatory activation of human macrophages regulated by lncRNAs$767,374
R01 · FY2019 · HL · contact PI
PARP9 and PARP14 in atherosclerosis$602,965
R01 · FY2019 · HL · contact PI
PARP9 and PARP14 in atherosclerosis$601,902
R01 · FY2018 · HL · contact PI
NAVBO Workshops at Vascular Biology 2018$40,000
R13 · FY2018 · HL · contact PI
PARP9 and PARP14 in atherosclerosis$600,869
R01 · FY2017 · HL · contact PI
PARP9 and PARP14 in atherosclerosis$619,242
R01 · FY2016 · HL · contact PI
Dll4 in macrophage activation$532,459
R01 · FY2015 · HL · contact PI
Dll4 in macrophage activation$533,970
R01 · FY2014 · HL · contact PI
Dll4 in macrophage activation$510,891
R01 · FY2013 · HL · contact PI
Dll4 in macrophage activation$556,962
R01 · FY2012 · HL · contact PI
Role of the CD40/CD40L dyad in atherosclerosis$362,282
R01 · FY2006 · HL · contact PI
Role of the CD40/CD40L dyad in atherosclerosis$371,000
R01 · FY2005 · HL
Role of the CD40/CD40L dyad in atherosclerosis$371,000
R01 · FY2004 · HL
Role of the CD40/CD40L dyad in atherosclerosis$396,000
R01 · FY2003 · HL